M3, Inc. (2413) Stock Price, Fundamentals & Analysis

What 2413 does

M3, Inc. (2413) is a Healthcare stock in the Health Information Services industry, listed on the Tokyo Stock Exchange. It operates online platforms and services for physicians, pharmacists, and other healthcare professionals. Its portfolio includes m3.com, a members-only website for medical professionals; MR-kun, which delivers daily medical news; QOL-kun, a marketing support service for doctors; m3.com CAREER, a physician recruitment platform; and Yakucari, a job search site for pharmacists. The company also provides online lectures, clinical trial services, research reports, survey panels, and management services for medical websites. Internationally, it operates AskDoctors, MDLinx for U.S. medical professionals, and Doctors.net.uk for pharmaceutical companies, along with a drug information database.

Key numbers explained

• 1,767.5 JPY is the current price, the latest trading value of one share.
• The trailing P/E ratio of 24.4 divides the current share price by the last twelve months of earnings (72.47 JPY), showing how much investors pay per unit of recent earnings.
• The forward P/E ratio of 24.7 uses expected future earnings, giving a sense of valuation relative to what the market anticipates.
• Dividend yield of 1.24% is the annual dividend payment expressed as a percentage of the share price; the exDividendDate is 30 mar. 2026.
• Beta of 0.48 indicates the stock has historically moved less than the overall market, often interpreted as lower volatility.
• Market cap of 1.18 tril. JPY reflects the total market value of all outstanding shares.
• Revenue, trailing twelve months, is 355,27 mld. JPY, with a year-over-year growth of 4.5%.
• Profit margin of 13% and operating margin of 18.4% show how much of each revenue yen remains as profit after costs and operating expenses.

What to watch

M3, Inc. (2413) is part of the Nikkei 225, a major Japanese index, and operates alongside peers such as Astellas (4503), Kyōwa Hakkō Kirin (4151), Eisai (4523), Terumo (4543), Chugai Pharmaceutical (4519), Takeda Pharmaceutical (4502), and Sumitomo Dainippon Pharma (4506). Investors typically monitor regulatory changes affecting healthcare and pharmaceutical data, shifts in online advertising and recruitment demand among professionals, and broader market movements in the Tokyo Stock Exchange stocks space. The stock’s price change over the last 52 weeks of -25.5% and its 52-week range of 1,297 – 2,746 show a wide price swing over the past year. The debt-to-equity ratio of 8.5% and return on equity of 12% are standard measures of financial leverage and shareholder return, respectively. The priceToBook of 2.9 compares the market price to the company’s book value per share. The nextEarningsDate is 4 nov. 2026.